Biokinetics of ultrafine gold nanoparticles (AuNPs) relating to redistribution and urinary excretion: a long-term in vivo study

Journal of Drug Targeting
Farhat NazAmit Kumar Dinda

Abstract

Gold nanoparticles (AuNPs) of ultrafine size have drawn attention for their use in drug delivery systems. Tissue toxicity may be an issue when AuNPs are used for such applications. We investigated the long-term biokinetics (90 d), redistribution, and urinary excretion of three different-sized (2 ± 0.5 nm, 5 ± 1 nm, and 10 ± 2 nm) AuNPs after a single intravenous (i.v.) administration of 1250 µg/kg dose in mice. ICP-AES analysis of lungs, liver, spleen, heart, kidney, brain, blood, and urine revealed highest accumulation of gold in spleen around 15 d after injection. A low concentration was detected in brain after 1 d without any residual AuNPs after 30 d. Ultrastructural study of brain tissue also showed few AuNPs in lysosome with no changes in cellular architecture. Renal retention of AuNPs was limited indicating low nephrotoxic potential. AuNPs were detectable in urine till 30 d after single injection indicating slow excretion from the body. No evidence of significant toxicity was observed in hemogram, serum biochemistry, and tissue histology. No mortality, changes in behavior, hair color, weight, and food intake was observed as compared to control mice. Therefore, we conclude that the ultrafine AuNPs are predominantly excret...Continue Reading

References

Aug 1, 1978·Veterinary Pathology·B J Payne, L Z Saunders
Feb 25, 2006·The British Journal of Radiology·J F HainfeldH M Smilowitz
Jan 27, 2007·Current Opinion in Biotechnology·Shelton D CaruthersGregory M Lanza
Sep 25, 2007·Nature Biotechnology·Hak Soo ChoiJohn V Frangioni
Oct 13, 2007·American Journal of Respiratory and Critical Care Medicine·Winfried MöllerWolfgang G Kreyling
Aug 30, 2008·Colloids and Surfaces. B, Biointerfaces·Ganeshchandra SonavaneKimiko Makino
Sep 3, 2008·Chemical Society Reviews·Ralph A SperlingWolfgang J Parak
Nov 26, 2008·Small·Manuela Semmler-BehnkeWolfgang Brandau
Feb 17, 2009·Nanomedicine : Nanotechnology, Biology, and Medicine·Evaldas SadauskasHåkan Wallin
Jul 10, 2009·Chemical Society Reviews·Elodie Boisselier, Didier Astruc
Dec 17, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Dakrong PissuwanMichael B Cortie
Feb 16, 2010·Biochemical and Biophysical Research Communications·C Lasagna-ReevesC Soto
Mar 3, 2010·Toxicology and Applied Pharmacology·Wan-Seob ChoMyung-Haing Cho
Jan 1, 2009·Nanoscale Research Letters·Yu-Shiun ChenG Steve Huang
Aug 10, 2010·Advanced Drug Delivery Reviews·Jin XieXiaoyuan Chen
Nov 3, 2010·International Journal of Nanomedicine·Xiao-Dong ZhangFei-Yue Fan
Nov 18, 2010·Chemical Society Reviews·Nikolai Khlebtsov, Lev Dykman
Dec 1, 2010·Methods in Molecular Biology·Jeffrey D Clogston, Anil K Patri
Dec 21, 2010·Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology·Alaaldin M Alkilany, Catherine J Murphy
Jan 5, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Stephanie HirnWolfgang G Kreyling
Jul 29, 2011·Nanomedicine·Joao Paulo Mattos AlmeidaRebekah Drezek
Sep 29, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Tiago MoraisMaria de Lourdes Bastos
Dec 2, 2011·Chemical Society Reviews·Lev Dykman, Nikolai Khlebtsov
Jul 10, 2012·Nanomedicine : Nanotechnology, Biology, and Medicine·Carrie A SimpsonDaniel L Feldheim
Oct 23, 2013·Pharmacological Reports : PR·Marek WojnickiKrzysztof Fitzner
Jan 18, 2014·The Journal of Physical Chemistry. B·Megan A MackeyMostafa A El-Sayed
Jun 19, 2014·Nanomedicine : Nanotechnology, Biology, and Medicine·Sónia FragaHelena Carmo
Jan 1, 2013·Materials Science & Engineering. C, Materials for Biological Applications·Marius StefanLucian Hritcu
May 21, 2015·Nanomaterials·Mi-Rae JoSoo-Jin Choi

❮ Previous
Next ❯

Citations

Dec 6, 2016·Artificial Cells, Nanomedicine, and Biotechnology·Dandan WangDeok Chun Yang
Feb 2, 2018·Advanced Materials·Joël BourquinBarbara Rothen-Rutishauser
Jan 7, 2020·Current Drug Metabolism·Pooja MalaviyaAbhay R Vasavada
May 11, 2018·Toxicologic Pathology·Javiera BahamondeM Renee Prater
May 10, 2017·Physiological Measurement·Richard BayfordScarlet Xiaoyan Wang
Oct 3, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Michele S MajoumouoMervin Meyer
Apr 10, 2020·Journal of the American Chemical Society·Elizabeth M Higbee-DempseyAndrew Tsourkas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.